241 – 250 of 715
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts.
(
- Contribution to journal › Article
-
Mark
Letter to the Editor: "Can early plasma elimination rate be used to quantify renal clearance of macromolecules?".
(
- Contribution to journal › Letter
-
Mark
Circulating microRNA expression pattern separates patients with anti-neutrophil cytoplasmic antibody associated vasculitis from healthy controls.
(
- Contribution to journal › Article
-
Mark
European Union funded project on the development of a whole complement deficiency screening ELISA-A story of success and an exceptional manager: Mohamed R. Daha.
(
- Contribution to journal › Scientific review
-
Mark
Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
(
- Contribution to journal › Article
-
Mark
Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial).
(
- Contribution to journal › Article
-
Mark
Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
(
- Contribution to journal › Article
-
Mark
Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis.
(
- Contribution to journal › Article
-
Mark
Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
(
- Contribution to journal › Article